Literature DB >> 32610141

Molecular Stressors Engender Protein Connectivity Dysfunction through Aberrant N-Glycosylation of a Chaperone.

Pengrong Yan1, Hardik J Patel1, Sahil Sharma1, Adriana Corben2, Tai Wang1, Palak Panchal1, Chenghua Yang3, Weilin Sun1, Thais L Araujo1, Anna Rodina1, Suhasini Joshi1, Kenneth Robzyk1, Srinivasa Gandu1, Julie R White4, Elisa de Stanchina5, Shanu Modi6, Yelena Y Janjigian6, Elizabeth G Hill7, Bei Liu8, Hediye Erdjument-Bromage9, Thomas A Neubert9, Nanette L S Que10, Zihai Li8, Daniel T Gewirth10, Tony Taldone1, Gabriela Chiosis11.   

Abstract

<span class="Disease">Stresses associated with disease may pathologically remodel the proteome by both increasing interaction strength and altering interaction partners, resulting in proteome-wide connectivity dysfunctions. Chaperones play an important role in these alterations, but how these changes are executed remains largely unknown. Our study unveils a specific N-glycosylation pattern used by a chaperone, Glucose-regulated protein 94 (GRP94), to alter its conformational fitness and stabilize a state most permissive for stable interactions with proteins at the plasma membrane. This "protein assembly mutation' remodels protein networks and properties of the cell. We show in cells, human specimens, and mouse xenografts that proteome connectivity is restorable by inhibition of the N-glycosylated GRP94 variant. In summary, we provide biochemical evidence for stressor-induced chaperone-mediated protein mis-assemblies and demonstrate how these alterations are actionable in disease.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  GRP94; aberrant N-glycosylation; aberrant protein-protein interaction; cellular stress; chaperome-mediated protein connectivity dysfunction; epichaperome; protein mis-assembly; stable protein assembly; stress-mediated molecular dysfunction; targeted protein degradation-based therapeutics

Mesh:

Substances:

Year:  2020        PMID: 32610141      PMCID: PMC7372946          DOI: 10.1016/j.celrep.2020.107840

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  85 in total

1.  Structure-activity relationship in a purine-scaffold compound series with selectivity for the endoplasmic reticulum Hsp90 paralog Grp94.

Authors:  Hardik J Patel; Pallav D Patel; Stefan O Ochiana; Pengrong Yan; Weilin Sun; Maulik R Patel; Smit K Shah; Elisa Tramentozzi; James Brooks; Alexander Bolaender; Liza Shrestha; Ralph Stephani; Paola Finotti; Cynthia Leifer; Zihai Li; Daniel T Gewirth; Tony Taldone; Gabriela Chiosis
Journal:  J Med Chem       Date:  2015-04-22       Impact factor: 7.446

2.  Perturbation of cellular calcium induces secretion of luminal ER proteins.

Authors:  C Booth; G L Koch
Journal:  Cell       Date:  1989-11-17       Impact factor: 41.582

Review 3.  EGFR targeted therapies and radiation: Optimizing efficacy by appropriate drug scheduling and patient selection.

Authors:  Kyle C Cuneo; Mukesh K Nyati; Dipankar Ray; Theodore S Lawrence
Journal:  Pharmacol Ther       Date:  2015-07-21       Impact factor: 12.310

4.  Molecular imaging of N-linked glycosylation suggests glycan biosynthesis is a novel target for cancer therapy.

Authors:  Joseph N Contessa; Mahaveer S Bhojani; Hudson H Freeze; Brian D Ross; Alnawaz Rehemtulla; Theodore S Lawrence
Journal:  Clin Cancer Res       Date:  2010-04-22       Impact factor: 12.531

5.  Radicicol-sensitive peptide binding to the N-terminal portion of GRP94.

Authors:  Shawn Vogen; Tali Gidalevitz; Chhanda Biswas; Birgitte B Simen; Eytan Stein; Funda Gulmen; Yair Argon
Journal:  J Biol Chem       Date:  2002-08-19       Impact factor: 5.157

6.  Fibroblast-secreted hepatocyte growth factor mediates epidermal growth factor receptor tyrosine kinase inhibitor resistance in triple-negative breast cancers through paracrine activation of Met.

Authors:  Kelly L Mueller; Julie M Madden; Gina L Zoratti; Charlotte Kuperwasser; Karin List; Julie L Boerner
Journal:  Breast Cancer Res       Date:  2012-07-12       Impact factor: 6.466

7.  Clinical Response to Sorafenib in a Patient with Metastatic Colorectal Cancer and FLT3 Amplification.

Authors:  Raphael Brandão Moreira; Renata D'Alpino Peixoto; Marcelo Rocha de Sousa Cruz
Journal:  Case Rep Oncol       Date:  2015-02-11

Review 8.  Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.

Authors:  Marc Brehme; Cindy Voisine
Journal:  Dis Model Mech       Date:  2016-08-01       Impact factor: 5.758

Review 9.  Receptor tyrosine kinases (RTKs) in breast cancer: signaling, therapeutic implications and challenges.

Authors:  Ramesh Butti; Sumit Das; Vinoth Prasanna Gunasekaran; Amit Singh Yadav; Dhiraj Kumar; Gopal C Kundu
Journal:  Mol Cancer       Date:  2018-02-19       Impact factor: 27.401

10.  HSP90-incorporating chaperome networks as biosensor for disease-related pathways in patient-specific midbrain dopamine neurons.

Authors:  Sarah Kishinevsky; Tai Wang; Anna Rodina; Sun Young Chung; Chao Xu; John Philip; Tony Taldone; Suhasini Joshi; Mary L Alpaugh; Alexander Bolaender; Simon Gutbier; Davinder Sandhu; Faranak Fattahi; Bastian Zimmer; Smit K Shah; Elizabeth Chang; Carmen Inda; John Koren; Nathalie G Saurat; Marcel Leist; Steven S Gross; Venkatraman E Seshan; Christine Klein; Mark J Tomishima; Hediye Erdjument-Bromage; Thomas A Neubert; Ronald C Henrickson; Gabriela Chiosis; Lorenz Studer
Journal:  Nat Commun       Date:  2018-10-19       Impact factor: 14.919

View more
  9 in total

Review 1.  The penalty of stress - Epichaperomes negatively reshaping the brain in neurodegenerative disorders.

Authors:  Stephen D Ginsberg; Suhasini Joshi; Sahil Sharma; Gianny Guzman; Tai Wang; Ottavio Arancio; Gabriela Chiosis
Journal:  J Neurochem       Date:  2021-10-31       Impact factor: 5.372

Review 2.  Disease-specific interactome alterations via epichaperomics: the case for Alzheimer's disease.

Authors:  Stephen D Ginsberg; Thomas A Neubert; Sahil Sharma; Chander S Digwal; Pengrong Yan; Calin Timbus; Tai Wang; Gabriela Chiosis
Journal:  FEBS J       Date:  2021-06-12       Impact factor: 5.622

Review 3.  The Role of Non-Canonical Hsp70s (Hsp110/Grp170) in Cancer.

Authors:  Graham Chakafana; Addmore Shonhai
Journal:  Cells       Date:  2021-01-28       Impact factor: 6.600

4.  Pharmacologically controlling protein-protein interactions through epichaperomes for therapeutic vulnerability in cancer.

Authors:  Suhasini Joshi; Erica DaGama Gomes; Tai Wang; Adriana Corben; Tony Taldone; Srinivasa Gandu; Chao Xu; Sahil Sharma; Salma Buddaseth; Pengrong Yan; Lon Yin L Chan; Askan Gokce; Vinagolu K Rajasekhar; Lisa Shrestha; Palak Panchal; Justina Almodovar; Chander S Digwal; Anna Rodina; Swathi Merugu; NagaVaraKishore Pillarsetty; Vlad Miclea; Radu I Peter; Wanyan Wang; Stephen D Ginsberg; Laura Tang; Marissa Mattar; Elisa de Stanchina; Kenneth H Yu; Maeve Lowery; Olivera Grbovic-Huezo; Eileen M O'Reilly; Yelena Janjigian; John H Healey; William R Jarnagin; Peter J Allen; Chris Sander; Hediye Erdjument-Bromage; Thomas A Neubert; Steven D Leach; Gabriela Chiosis
Journal:  Commun Biol       Date:  2021-11-25

Review 5.  Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy.

Authors:  Ji Woong Kim; Yea Bin Cho; Sukmook Lee
Journal:  Cells       Date:  2021-03-17       Impact factor: 6.600

6.  Myeloid Endoplasmic Reticulum Resident Chaperone GP96 Facilitates Inflammation and Steatosis in Alcohol-Associated Liver Disease.

Authors:  Anuradha Ratna; Arlene Lim; Zihai Li; Josepmaria Argemi; Ramon Bataller; Gabriela Chiosis; Pranoti Mandrekar
Journal:  Hepatol Commun       Date:  2021-05-22

7.  Type 2 dendritic cells mediate control of cytotoxic T cell resistant tumors.

Authors:  Stephen Iwanowycz; Soo Ngoi; Yingqi Li; Megan Hill; Christopher Koivisto; Melodie Parrish; Beichu Guo; Zihai Li; Bei Liu
Journal:  JCI Insight       Date:  2021-09-08

8.  The GRP94 Inhibitor PU-WS13 Decreases M2-like Macrophages in Murine TNBC Tumors: A Pharmaco-Imaging Study with 99mTc-Tilmanocept SPECT.

Authors:  Alexanne Bouchard; Hugo Sikner; Valentin Baverel; Anaïs-Rachel Garnier; Marie Monterrat; Mathieu Moreau; Emeric Limagne; Carmen Garrido; Evelyne Kohli; Bertrand Collin; Pierre-Simon Bellaye
Journal:  Cells       Date:  2021-12-02       Impact factor: 6.600

9.  Chemical tools for epichaperome-mediated interactome dysfunctions of the central nervous system.

Authors:  Alexander Bolaender; Danuta Zatorska; Huazhong He; Suhasini Joshi; Sahil Sharma; Chander S Digwal; Hardik J Patel; Weilin Sun; Brandon S Imber; Stefan O Ochiana; Maulik R Patel; Liza Shrestha; Smit K Shah; Shuo Wang; Rashad Karimov; Hui Tao; Pallav D Patel; Ananda Rodilla Martin; Pengrong Yan; Palak Panchal; Justina Almodovar; Adriana Corben; Andreas Rimner; Stephen D Ginsberg; Serge Lyashchenko; Eva Burnazi; Anson Ku; Teja Kalidindi; Sang Gyu Lee; Milan Grkovski; Bradley J Beattie; Pat Zanzonico; Jason S Lewis; Steve Larson; Anna Rodina; Nagavarakishore Pillarsetty; Viviane Tabar; Mark P Dunphy; Tony Taldone; Fumiko Shimizu; Gabriela Chiosis
Journal:  Nat Commun       Date:  2021-08-03       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.